Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
VX-670
DRUG
2 trials
Sponsors
Vertex Pharmaceuticals Incorporated
Conditions
Myotonic Dystrophy Type 1 (DM1)
Phase 1
A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)
Active, not recruiting
NCT06185764
Vertex Pharmaceuticals Incorporated
Myotonic Dystrophy Type 1 (DM1)
Start: 2024-02-20
End: 2027-02-02
Updated: 2026-08-20
Phase 2
A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I
Enrolling by invitation
NCT06926621
Vertex Pharmaceuticals Incorporated
Myotonic Dystrophy Type 1 (DM1)
Start: 2025-04-28
End: 2029-01-30
Target: 44
Updated: 2026-08-10